234 related articles for article (PubMed ID: 7560615)
21. Selective versus routine predischarge coronary arteriography after therapy with recombinant tissue-type plasminogen activator, heparin and aspirin for acute myocardial infarction. TIMI II Investigators.
Rogers WJ; Babb JD; Baim DS; Chesebro JH; Gore JM; Roberts R; Williams DO; Frederick M; Passamani ER; Braunwald E
J Am Coll Cardiol; 1991 Apr; 17(5):1007-16. PubMed ID: 1901071
[TBL] [Abstract][Full Text] [Related]
22. Thrombolytic therapy for women with myocardial infarction: is there a gender gap? Thrombolysis and Angioplasty in Myocardial Infarction Study Group.
Lincoff AM; Califf RM; Ellis SG; Sigmon KN; Lee KL; Leimberger JD; Topol EJ
J Am Coll Cardiol; 1993 Dec; 22(7):1780-7. PubMed ID: 8245328
[TBL] [Abstract][Full Text] [Related]
23. Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
Mak KH; Moliterno DJ; Granger CB; Miller DP; White HD; Wilcox RG; Califf RM; Topol EJ
J Am Coll Cardiol; 1997 Jul; 30(1):171-9. PubMed ID: 9207639
[TBL] [Abstract][Full Text] [Related]
24. Thrombolytic therapy for patients with prior percutaneous transluminal coronary angioplasty and subsequent acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.
Labinaz M; Sketch MH; Stebbins AL; DeFranco AC; Holmes DR; Kleiman NS; Betriu A; Rutsch WR; Vahanian A; Topol EJ; Califf RM
Am J Cardiol; 1996 Dec; 78(12):1338-44. PubMed ID: 8970403
[TBL] [Abstract][Full Text] [Related]
25. Clinical experience with primary percutaneous transluminal coronary angioplasty compared with alteplase (recombinant tissue-type plasminogen activator) in patients with acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2).
Tiefenbrunn AJ; Chandra NC; French WJ; Gore JM; Rogers WJ
J Am Coll Cardiol; 1998 May; 31(6):1240-5. PubMed ID: 9581714
[TBL] [Abstract][Full Text] [Related]
26. Effect on outcome of the presence or absence of chest pain at initiation of recombinant tissue plasminogen activator therapy in acute myocardial infarction. The Thrombolysis in Myocardial Infarction Investigators.
Cox DA; Rogers WJ; Aguirre FV; Forman S; Solomon R; Zaret BL
Am J Cardiol; 1994 Apr; 73(11):729-36. PubMed ID: 8160607
[TBL] [Abstract][Full Text] [Related]
27. Early coronary intervention following pharmacologic therapy for acute myocardial infarction (the combined TIMI 10B-TIMI 14 experience).
Schweiger MJ; Cannon CP; Murphy SA; Gibson CM; Cook JR; Giugliano RP; Changezi HU; Antman EM; Braunwald E;
Am J Cardiol; 2001 Oct; 88(8):831-6. PubMed ID: 11676942
[TBL] [Abstract][Full Text] [Related]
28. Late assessment of thrombolytic efficacy (LATE) study: prognosis in patients with non-Q wave myocardial infarction. (LATE Study Investigators).
Langer A; Goodman SG; Topol EJ; Charlesworth A; Skene AM; Wilcox RG; Armstrong PW
J Am Coll Cardiol; 1996 May; 27(6):1327-32. PubMed ID: 8626939
[TBL] [Abstract][Full Text] [Related]
29. Incomplete recanalization as an important determinant of Thrombolysis in Myocardial Infarction (TIMI) grade 2 flow after thrombolytic therapy for acute myocardial infarction. TEAM Investigators. Thrombolytic Trial of Eminase in Acute Myocardial Infarction.
Zahger D; Karagounis LA; Cercek B; Anderson JL; Sorensen S; Moreno F; Shah PK
Am J Cardiol; 1995 Oct; 76(11):749-52. PubMed ID: 7572648
[TBL] [Abstract][Full Text] [Related]
30. Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction.
Gershlick AH; Stephens-Lloyd A; Hughes S; Abrams KR; Stevens SE; Uren NG; de Belder A; Davis J; Pitt M; Banning A; Baumbach A; Shiu MF; Schofield P; Dawkins KD; Henderson RA; Oldroyd KG; Wilcox R;
N Engl J Med; 2005 Dec; 353(26):2758-68. PubMed ID: 16382062
[TBL] [Abstract][Full Text] [Related]
31. Early and six-month outcome in patients with angina pectoris early after acute myocardial infarction (the GISSI-3 APPI [angina precoce post-infarto] study).
GISSI-3 APPI Study Group
Am J Cardiol; 1996 Dec; 78(11):1191-7. PubMed ID: 8960573
[TBL] [Abstract][Full Text] [Related]
32. Inverse relation between diastolic blood pressure and long-term outcomes in patients undergoing pharmacoinvasive therapy for myocardial infarction: the J-shaped relation in the contemporary era of revascularisation.
Lee CH; Foo D; Wong HB; Hong EC; Seow SC; Ng KS; Lim YT; Tan HC
J Cardiovasc Med (Hagerstown); 2006 Nov; 7(11):806-11. PubMed ID: 17060806
[TBL] [Abstract][Full Text] [Related]
33. Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator. Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II-A trial.
Rogers WJ; Baim DS; Gore JM; Brown BG; Roberts R; Williams DO; Chesebro JH; Babb JD; Sheehan FH; Wackers FJ
Circulation; 1990 May; 81(5):1457-76. PubMed ID: 2110033
[TBL] [Abstract][Full Text] [Related]
34. Early reinfarction after fibrinolysis: experience from the global utilization of streptokinase and tissue plasminogen activator (alteplase) for occluded coronary arteries (GUSTO I) and global use of strategies to open occluded coronary arteries (GUSTO III) trials.
Hudson MP; Granger CB; Topol EJ; Pieper KS; Armstrong PW; Barbash GI; Guerci AD; Vahanian A; Califf RM; Ohman EM
Circulation; 2001 Sep; 104(11):1229-35. PubMed ID: 11551872
[TBL] [Abstract][Full Text] [Related]
35. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review.
Weaver WD; Simes RJ; Betriu A; Grines CL; Zijlstra F; Garcia E; Grinfeld L; Gibbons RJ; Ribeiro EE; DeWood MA; Ribichini F
JAMA; 1997 Dec; 278(23):2093-8. PubMed ID: 9403425
[TBL] [Abstract][Full Text] [Related]
36. Reinfarction after thrombolytic therapy for acute myocardial infarction followed by conservative management: incidence and effect of smoking.
Rivers JT; White HD; Cross DB; Williams BF; Norris RM
J Am Coll Cardiol; 1990 Aug; 16(2):340-8. PubMed ID: 2115538
[TBL] [Abstract][Full Text] [Related]
37. High-grade infarct-related stenosis after successful thrombolysis: strong predictor of reocclusion, but not of clinical reinfarction.
Kievit PC; Brouwer MA; Veen G; Karreman AJ; Verheugt FW
Am Heart J; 2004 Nov; 148(5):826-33. PubMed ID: 15523313
[TBL] [Abstract][Full Text] [Related]
38. Coronary intervention for persistent occlusion after myocardial infarction.
Hochman JS; Lamas GA; Buller CE; Dzavik V; Reynolds HR; Abramsky SJ; Forman S; Ruzyllo W; Maggioni AP; White H; Sadowski Z; Carvalho AC; Rankin JM; Renkin JP; Steg PG; Mascette AM; Sopko G; Pfisterer ME; Leor J; Fridrich V; Mark DB; Knatterud GL;
N Engl J Med; 2006 Dec; 355(23):2395-407. PubMed ID: 17105759
[TBL] [Abstract][Full Text] [Related]
39. Gender and acute myocardial infarction: is there a different response to thrombolysis?
Woodfield SL; Lundergan CF; Reiner JS; Thompson MA; Rohrbeck SC; Deychak Y; Smith JO; Burton JR; McCarthy WF; Califf RM; White HD; Weaver WD; Topol EJ; Ross AM
J Am Coll Cardiol; 1997 Jan; 29(1):35-42. PubMed ID: 8996292
[TBL] [Abstract][Full Text] [Related]
40. Can exercise testing in patients with a history of myocardial infarction predict fatal and non-fatal reinfarction?
Casella G; Pavesi PC; di Niro M; Medda M; Camplese MG; Bracchetti D
G Ital Cardiol; 1998 Jan; 28(1):12-21. PubMed ID: 9493041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
